Study finds good and bad news about rosiglitazone (Avandia).
Findings from A Diabetes Outcome Progression Trial (ADOPT) study were met with both excitement and caution following a presentation at the International Diabetes Federation's World Diabetes Congress in Cape Town in early December. The study was designed to compare the ability of rosiglitazone (Avandia), metformin and...